pharmacotherapy for alcohol use disorders: physicians’ perceptions and practices
Clicks: 291
ID: 249041
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
291 views
33 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #95 of 188 articles by views in journal of experimental psychology general
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 188 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background and ObjectivesAlcohol use disorders (AUDs) are an important cause of morbidity and mortality. Despite the NIAAA’s recommendations that medications be considered for patients with alcohol dependence, the mainstay of treatment has been counseling. We designed a survey to assess the treatment practices of Psychiatrists and Family Medicine (FM) physicians, in an effort to identify barriers to the use of pharmacotherapy and develop strategies to increase physician knowledge and utilization of these medications.MethodsAn anonymous online survey was sent to FM physicians and Psychiatrists nationwide. The survey collected demographic information and assessed prescription of medications in treating AUDs, including FDA-approved medications and other medications used off-label for this purpose. We also examined factors that would lead to an increase in AUDs pharmacotherapy.ResultsA total of 491 surveys were completed, with 475 responses included in the final analyses. 45.5% of participants were Psychiatrists vs. 54.5% FM physicians. 74.7% respondents had used medications to treat AUDs, with Psychiatrists more likely to have prescribed acamprosate, naltrexone, and several off-label medications. FM physicians were more likely to report efficacy concerns. A majority of all physicians sampled would increase pharmacotherapy of AUDs with increased training.DiscussionIn our sample, most physicians have used medications to treat AUDs. There were concerns about efficacy with all non-FDA approved medications, but limited treatment success even with FDA-approved medications. Greater education about pharmacotherapy, including predictors for treatment response amongst patients, should help alleviate some of the uncertainties reported with medications’ efficacy and lead to a more
| Reference Key |
martinez2016frontierspharmacotherapy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Caridad Ponce Martinez;Vakkalanka Priyanka;Nassima Ait-Daoud Tiouririne |
| Journal | journal of experimental psychology general |
| Year | 2016 |
| DOI |
10.3389/fpsyt.2016.00182
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.